Lipid metabolism

2022 Activity indicators

  • 3 national public competitive projects led
  • 1 international competitive project
  • 1 private project led
  • 1 observational study led
  • 6 competitive HR contracts
  • 21 publications
  • IF: 158.84
  • Q1 publications: 11 (52%)
  • D1 publications: 3 (14%)
  • Evaluators of national public agencies: 5 group members
  • Members of Editorial Committees: 1 group member
  • 5 months of stay in foreign centres
    • Yale School of Medicine (USA)
  • 4 visitors hosted and 16 months of stay
    • Antonio Machado Secondary School
    • IES Moratalaz
    • University of Alcalá
  • Protection of a method for the prognosis of the efficacy of oral immunotherapy for the treatment of cow's milk protein allergy. Patent family extended internationally to 5 countries.

Milestones

  1. In cellular and murine models, ellagic acid and its metabolites, urolithins, ameliorate alterations associated with lysosomal storage diseases by increasing the production of secretory vesicles.
  2. Impaired lipid homeostasis in the testis is associated with infertility in obese patients and mice.
  3. IgG4 antibodies against Ara h 9 peptide 4 may be useful for the diagnosis of peanut allergy.
  4. Description of a new family of delta 4-desaturase, sphingolipid 1 (DEGS1) inhibitors with beneficial effects on fatty liver.
  5. Participation in the CLIG-Trial (Clinical Lipidomics Interest Group) international network.

Bibliometrics

 

Articles

Accum. IF

Mean IF

Articles Q1 or Q2

% in Q1 or Q2

Articles D1

% in D1

2018 13 53,87 4,14 9 69 3 23
2019 21 101,66 4,84 18 86 7 33
2020 22 108,55 4,93 15 68 3 14
2021 25 133,92 5,36 20 80 5 20
2022 21 158,84 7,56 16 76 3 14
  102 556,84 5,37 78 76 21 21

* Only original articles, editorials, guidelines and reviews

Networks and alliances